Variant report
Variant | nsv824629 |
---|---|
Chromosome Location | chr8:52660203-52661913 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145561845 | chr8:52660267-52660268 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542806599 | chr8:52660330-52660331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536654250 | chr8:52660526-52660527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148915622 | chr8:52660527-52660528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540149278 | chr8:52660550-52660551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549731154 | chr8:52660585-52660586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182680641 | chr8:52660596-52660597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531992157 | chr8:52660672-52660673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544317943 | chr8:52660678-52660679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566254608 | chr8:52660717-52660718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554714418 | chr8:52660753-52660754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531018916 | chr8:52660814-52660815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549118205 | chr8:52660862-52660863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528742777 | chr8:52660867-52660868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142696949 | chr8:52660876-52660877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546959690 | chr8:52660884-52660885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558192092 | chr8:52660890-52660891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs4873204 | chr8:52660930-52660931 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs77025783 | chr8:52660964-52660965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557502194 | chr8:52660988-52660989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569329515 | chr8:52660989-52660990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536743106 | chr8:52661012-52661013 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs117134887 | chr8:52661025-52661026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572938189 | chr8:52661045-52661046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540549275 | chr8:52661062-52661063 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558545294 | chr8:52661080-52661081 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576788955 | chr8:52661112-52661113 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187003418 | chr8:52661159-52661160 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs151000462 | chr8:52661209-52661210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141238524 | chr8:52661255-52661256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144962144 | chr8:52661321-52661322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574376751 | chr8:52661322-52661323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191781813 | chr8:52661328-52661329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183563542 | chr8:52661334-52661335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565402493 | chr8:52661354-52661355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532544078 | chr8:52661398-52661399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551044077 | chr8:52661428-52661429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569266884 | chr8:52661453-52661454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536779087 | chr8:52661479-52661480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548680994 | chr8:52661488-52661489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188606973 | chr8:52661507-52661508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146825988 | chr8:52661515-52661516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557094374 | chr8:52661544-52661545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376135286 | chr8:52661598-52661599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558823959 | chr8:52661662-52661663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140605340 | chr8:52661766-52661767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567357861 | chr8:52661789-52661790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4543529 | chr8:52661793-52661794 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs555779033 | chr8:52661839-52661840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150468606 | chr8:52661864-52661865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:52644000-52665400 | Weak transcription | Right Ventricle | heart |
2 | chr8:52658600-52661000 | Weak transcription | Right Atrium | heart |
3 | chr8:52659800-52661000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr8:52660200-52660800 | Enhancers | Fetal Kidney | kidney |
5 | chr8:52660200-52661400 | Enhancers | Psoas Muscle | Psoas |
6 | chr8:52660400-52661400 | Enhancers | Left Ventricle | heart |
7 | chr8:52660800-52665200 | Weak transcription | Fetal Kidney | kidney |
8 | chr8:52661000-52661200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr8:52661000-52661400 | Enhancers | Fetal Muscle Trunk | muscle |
10 | chr8:52661000-52661400 | Enhancers | Right Atrium | heart |
11 | chr8:52661000-52661400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
12 | chr8:52661200-52665000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr8:52661400-52666400 | Weak transcription | Psoas Muscle | Psoas |
14 | chr8:52661400-52671400 | Weak transcription | Right Atrium | heart |
15 | chr8:52661400-52683200 | Weak transcription | Left Ventricle | heart |
16 | chr8:52661600-52664400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |